Sumitomo Chemical India (NSE: SUMICHEM) reported standalone total income of ₹934.27 crore and standalone net profit of ₹156.04 crore for the quarter ended 30 Sep 2026. Consolidated net profit attributable to owners was ₹157.24 crore for the same quarter.
Key highlights
Consolidated
Including its subsidiaries
Net profit: ₹157.24 crore attributable to owners, against ₹177.77 crore a year earlier
EPS: ₹3.14 basic, against ₹3.56 a year earlier
Revenue from operations: ₹907.31 crore, down 2.4% YoY and 14.7% QoQ
Other income: ₹43.59 crore, up 12.3% YoY
Standalone
The company on its own, without its subsidiaries
Total income: ₹934.27 crore, down 2.0% YoY and 15.2% QoQ
Net profit: ₹156.04 crore, down 12.3% YoY and 27.9% QoQ
EPS: ₹3.13 basic, against ₹3.56 a year earlier
Finance costs: ₹1.58 crore, against ₹1.90 crore a year earlier
Summary
Consolidated ₹ crore
Particulars
Q2 FY27
Q2 FY26
YoY
Q1 FY27
QoQ
907.31
929.82
-2.4%
1,063.35
-14.7%
Other income
43.59
38.80
+12.3%
47.28
-7.8%
Profit before tax
210.17
237.85
-11.6%
288.24
-27.1%
Finance costs
1.92
2.24
-13.9%
2.00
-3.8%
Depreciation
17.27
16.75
+3.1%
17.23
+0.2%
Tax expense
52.76
60.08
-12.2%
73.73
-28.4%
EPS, basic (₹)
3.14
3.56
-11.8%
4.30
-27.0%
Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.
Operating revenue fell while other income rose. Consolidated revenue from operations was ₹907.31 crore, down 2.4% from ₹929.82 crore a year earlier and 14.7% below the June quarter. Other income rose 12.3% to ₹43.59 crore, which is 20.7% of profit before tax of ₹210.17 crore.
Profit before tax fell 11.6% to ₹210.17 crore. Tax expense of ₹52.76 crore is 25.1% of that profit, against 25.3% a year earlier, so the effective rate was close to the year-ago level.
The June quarter is the high base for the sequential comparison. The statement shows an exceptional item of ₹26.90 crore in the quarter ended 30 Jun 2026, an insurance claim for business interruption from the Bhavnagar plant fire in FY 2022-23, and none in the quarter under review. Against that quarter, profit before tax fell 27.1%.
Finance costs were ₹1.92 crore and depreciation ₹17.27 crore, both small beside the operating line. Depreciation rose 3.1% YoY, while finance costs fell 13.9%.
Standalone ₹ crore
Particulars
Q2 FY27
Q2 FY26
YoY
Q1 FY27
QoQ
934.27
953.14
-2.0%
1,101.14
-15.2%
Revenue from operations
890.91
914.44
-2.6%
1,054.08
-15.5%
Other income
43.36
38.70
+12.1%
47.06
-7.9%
156.04
177.90
-12.3%
216.53
-27.9%
Profit before tax
208.82
237.87
-12.2%
291.26
-28.3%
Finance costs
1.58
1.90
-16.7%
1.64
-3.6%
Depreciation
16.24
15.87
+2.3%
16.23
0.0%
Tax expense
52.78
59.98
-12.0%
74.73
-29.4%
Net profit margin
16.70%
18.66%
-1.96 pp
19.66%
-2.96 pp
EPS, basic (₹)
3.13
3.56
-12.1%
4.34
-27.9%
Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.
Standalone net profit fell faster than total income. Net profit of ₹156.04 crore was down 12.3% YoY, while total income of ₹934.27 crore was down 2.0%. The net profit margin on total income was 16.70%, against 18.66% a year earlier.
Other income of ₹43.36 crore, up 12.1%, is 4.6% of total income and 20.8% of profit before tax of ₹208.82 crore. Standalone tax expense of ₹52.78 crore is 25.3% of profit before tax.
Glyphosate is the notes' main open matter. A Central Government notification of October 2022 requires glyphosate to be used only through Pest Control Operators, and industry petitions challenging it are before the Delhi High Court. The Government's counsel has told the court the notification will not be implemented until the petitions are disposed of, and the petitions are still being heard.
The business is seasonal and depends on monsoon and other climatic conditions, and the company has one reportable segment, agro-chemicals. Dividend paid in the half year to 30 Sep 2026 was ₹64.78 crore. Related party transactions in the period totalled ₹459.97 crore, including sales and purchases with the holding company Sumitomo Chemical Company Limited.
Inference
Paid-up equity share capital is ₹499.15 crore at a face value of ₹10 per share, and consolidated total assets were ₹4,979.50 crore at 30 Sep 2026, against ₹4,474.19 crore at 31 Mar 2026.
The filing does not say whether a dividend has been declared for the quarter or its amount per share, and it gives no date for the outcome of the glyphosate petitions.
Create a free account to read the rest of this article and the analysis that follows.
By continuing you agree to our Terms and Privacy Policy, and to receive updates from Blacklitt by email. You can unsubscribe anytime.
Disclaimer:
The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.
SUMICHEMSumitomo Chemical India Ltd.
